国药现代(600420.SH)：碳酸氢钠注射液增加规格并通过仿制药一致性评价

Core Viewpoint - The company, China National Pharmaceutical Group Modern (国药现代), announced that its wholly-owned subsidiary, China National Pharmaceutical Group Rongsheng Pharmaceutical Co., Ltd. (国药容生), received approval from the National Medical Products Administration for a supplementary application regarding sodium bicarbonate injection, which has now passed the consistency evaluation for generic drug quality and efficacy [1] Group 1 - The approved sodium bicarbonate injection will have an increased specification and has been granted a drug approval number [1] - Sodium bicarbonate injection is classified as an antacid and is indicated for the treatment of metabolic acidosis [1] - The injection is also used for the prevention of uric acid kidney stones, to reduce the nephrotoxicity of sulfonamide drugs, and to prevent hemoglobin deposition in renal tubules during acute hemolysis [1] Group 2 - Additionally, sodium bicarbonate injection has non-specific therapeutic effects for certain drug poisonings, such as barbiturates, salicylates, and methanol [1]